\

 

 


 

The Gynecologic Oncology Group (GOG) is a non-profit international organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of Gynecologic malignancies. The Group is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. Continuous evaluation of our processes is utilized in order to constantly improve the quality of patient care. To promote this mission, the GOG receives support from the National Cancer Institute (NCI) of the National Institutes for Health (NIH).

Approximately 45 individual clinical trials are active at any one time within GOG for patients with a variety of gynecologic malignancies, including cancers that arise from the ovaries, uterus, cervix, vagina, and vulva. General information on many of these trials for medical professionals and the lay public can be obtained from the NCI PDQ clinical trials database. 

 

GOG- 0240 Article: Bevacizumab Significantly Improves Survival For Patients With Recurrent and Metastatic Cervical Cancer

 

 

 
Upcoming Events



 


    Latest News


    Training Videos

 

    Helpful Links

 

 

 

 

 

 

.


  Home   Contact Us   Privacy Policy   Reporting Copyright Infringements  Site Help   Site Map